Question 1

What specific benefits might I gain from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the CIK cell treatment compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody clinical trial (NCT03282435). Contact the study team or your healthcare provider for specific answers.

What this study is about